NASA’s “super plastic” part of implantable device for heart failure patientsMay 7th, 2009 - 1:55 pm ICT by ANI
Washington, May 7 (ANI): NASA researchers have developed a “super plastic” that is now part of an implantable device for heart failure patients.
The technology was originally developed for an aerospace high-speed research program.
The “super plastic” was determined to be biologically inert, making it suitable for medical use, including implantable devices.
It is highly flexible, resistant to chemicals, and withstands extreme hot and cold temperatures.
“One of the advantages of this material is that it lends itself to a variety of diverse applications, from mechanical parts and composites to electrical insulation and adhesive bonding,” said Rob Bryant, a NASA Langley senior researcher and inventor of the material.
In July 2004, NASA licensed the patented insulation technology to Medtronic Inc., a Minneapolis-based medical technology company. Medtronic Inc. incorporated the material into its Attain Ability left-heart lead, which the U.S. Food and Drug Administration recently approved.
The use of this NASA-developed material in a medical implant is the latest in a long line of medical applications that have benefited from NASA technology.
Heart failure occurs when the heart muscle is unable to pump effectively to meet the body’s need for blood and oxygen.
It is a chronic and progressive condition that affects more than five million Americans and more than 22 million individuals worldwide.
Cardiac resynchronization therapy, or CRT, is designed to coordinate the contraction of the heart’s two lower chambers and improve the heart’s efficiency to increase blood flow to the body.
CRT devices, which are stopwatch-sized, are implanted into the chest and connected to the heart by leads, such as the Attain Ability left-heart lead.
A lead is a special wire that delivers energy from a CRT to the heart muscle. Electrical impulses generated by CRTs resynchronize heartbeats and improve blood flow.
The NASA insulation material makes possible the compact and flexible design of Medtronic’s CRT lead, one of the thinnest left-heart leads available.
Placing a lead in the heart is widely recognized by physicians as the most challenging aspect of implanting CRT devices.
The narrow design allows physicians to choose between different sites on the heart to deliver optimal therapy.
The lead is delivered by an inner catheter, a feature that helps physicians place the lead directly in difficult-to-reach areas of the heart. (ANI)
- New implant synchronizes and strengthens fading heart beat: Study - Nov 15, 2010
- St. Jude to provide latest medical technologies to India - Apr 19, 2012
- Therapy to prevent heart failure more beneficial for women than men - Feb 08, 2011
- Women derive double benefit from heart failure device than men - May 14, 2010
- New therapy prevents heart failure - Jun 24, 2009
- New therapy to prevent heart failure - Sep 02, 2009
- Discarded "boob tubes" could cause big pollution problems - Feb 21, 2010
- Tiny diagnostic device can navigate bloodstream - Feb 23, 2012
- Human heartbeats could one day power cell phones! - Nov 12, 2010
- New surgical tool peers into heart non invasively - Mar 08, 2011
- All-in-one cardiac catheter to make heart surgeries simpler, better - Mar 07, 2011
- Device boosts libido of men with heart failure - Jun 02, 2011
- Now, a device to shield cardiac patients from stroke - Mar 28, 2012
- Implantable artificial kidney set to make dialysis history - Sep 03, 2010
- Heartbeats tapped to generate power for implant - May 21, 2010
Tags: adhesive bonding, cardiac resynchronization therapy, cold temperatures, electrical impulses, electrical insulation, food and drug administration, heart failure, heart failure patients, heart muscle, high speed research, implantable devices, insulation technology, left heart, medical implant, medical technology company, medtronic inc, nasa langley, nasa researchers, nasa technology, progressive condition